Stock YBGJ YUBO INTERNATIONAL BIOTECH LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Company Yubo International Biotech Limited

Equities

YBGJ

US9883661004

Biotechnology & Medical Research

Market Closed - OTC Markets
Other stock markets
 10:51:53 2024-04-30 EDT 		5-day change 1st Jan Change
0.3487 USD +39.54% Intraday chart for Yubo International Biotech Limited +66.05% +16.23%
04-12 Yubo International Biotech Limited Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 Yubo International Biotech Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI

Business Summary

Yubo International Biotech Ltd, formerly Magna-Lab Inc, is a holding company primarily operating through its subsidiary. The Company focuses on the research and development and application of endometrial stem cells and offers its products and services under the brand VIVCELL. The Company’s product offerings include healthcare products for respiratory system, skincare products, hair care products, healthy beverages and male and female personal care products. The Company also offers stem cell related services including cell testing and health management consulting services.

Number of employees: 18

Sales per Business

USD in Million2022Weight2023Weight Delta
Health Management and Health Maintenance Services
100.0 %
0 100.0 % 1 100.0 % +479.84%

Sales per region

USD in Million2022Weight2023Weight Delta
China
100.0 %
0 100.0 % 1 100.0 % +479.84%

Managers

Managers TitleAgeSince
Jun Wang CEO
 Chief Executive Officer 57 18-12-31
Lina Liu DFI
 Director of Finance/CFO 45 18-12-31
Wang Yang BRD
 Director/Board Member 45 18-12-31

Members of the board

Members of the board TitleAgeSince
Wang Yang BRD
 Director/Board Member 45 18-12-31
Lina Liu DFI
 Director of Finance/CFO 45 18-12-31
Zhi Hui Bai BRD
 Director/Board Member 39 19-12-31
Jun Wang CEO
 Chief Executive Officer 57 18-12-31

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 4,447 0 0 6.632 %
Stock B 1 119,816,343 7,945,985 ( 6.632 %) 0

Shareholders

NameEquities%Valuation
Wang Jun
33.34 %
39,943,800 33.34 % 40 M $
Boao Biotech Ltd.
20.84 %
24,967,800 20.84 % 25 M $
Wang Yang
16.03 %
19,211,400 16.03 % 19 M $
Focusone Technology Group Ltd.
9.618 %
11,524,500 9.618 % 11 M $
Focus Draw Group Ltd.
7.596 %
9,101,400 7.596 % 9 M $
World Precision Medicine Technology Ltd.
4.479 %
5,366,458 4.479 % 5 M $
Ho Shun Cheung
1.465 %
1,755,000 1.465 % 2 M $

Company contact information

Yubo International Biotech Ltd.

Room 105, Building 5 31 Xishiku Avenue

100034, Beijing

+

http://www.yubogroup.com
address Yubo International Biotech Limited(YBGJ)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Other Biotechnology & Medical Research

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
YUBO INTERNATIONAL BIOTECH LIMITED Stock Yubo International Biotech Limited
+16.23% 41.78M
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
+0.17% 42.19B
MODERNA, INC. Stock Moderna, Inc.
+10.92% 42.24B
LONZA GROUP AG Stock Lonza Group AG
+44.30% 40.15B
CELLTRION, INC. Stock Celltrion, Inc.
-6.20% 28.31B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+5.23% 24.63B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-24.79% 18.2B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+26.69% 12.01B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stock Charles River Laboratories International, Inc.
-3.13% 11.76B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+6.57% 10.4B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. YBGJ Stock
  4. Company Yubo International Biotech Limited